2013
DOI: 10.1016/j.pan.2013.04.084
|View full text |Cite
|
Sign up to set email alerts
|

CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
23
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(23 citation statements)
references
References 0 publications
0
23
0
Order By: Relevance
“…This could result from the inhibition of CDK6 that we observed in these cells, loss of CDK6 being a marker of several PDAC cell line invasiveness [44]. This may also be due to other properties of miR-29a that depend on the cellular context: increased invasion through MMP2, E-cadherin and KLF4 in colorectal cancer cells [45], decreased invasion in gastric [46], lung and pancreatic cancer cells [47], or decreased invasion and metastasis probably through the inhibition of CEACAM6 in pancreatic cancer [48]. Additionally, we found that overexpression of miR-29a or miR-330-5p sensitizes PDAC cells to gemcitabine and induces a decrease of Akt pathway activation.…”
Section: Discussionmentioning
confidence: 77%
“…This could result from the inhibition of CDK6 that we observed in these cells, loss of CDK6 being a marker of several PDAC cell line invasiveness [44]. This may also be due to other properties of miR-29a that depend on the cellular context: increased invasion through MMP2, E-cadherin and KLF4 in colorectal cancer cells [45], decreased invasion in gastric [46], lung and pancreatic cancer cells [47], or decreased invasion and metastasis probably through the inhibition of CEACAM6 in pancreatic cancer [48]. Additionally, we found that overexpression of miR-29a or miR-330-5p sensitizes PDAC cells to gemcitabine and induces a decrease of Akt pathway activation.…”
Section: Discussionmentioning
confidence: 77%
“…Among others, this led to the identification of CEACAM genes, which encode membrane-bound members of the immunoglobulin superfamily, overexpressed in many cancers and associated with adhesion and invasion [22,23]. In addition, CEACAM6 was reported to attenuate the adenovirus infection in cancer cells by antagonizing intracellular trafficking [24].…”
Section: Discussionmentioning
confidence: 99%
“…By contrast, CEACAM6 expression is up-regulated in many epithelial malignancies, including pancreatic, colorectal, breast, gastric, and lung adenocarcinomas, and its overexpression is associated with poor clinical outcomes [10][11][12][13][14][15][16][17]. In pancreatic cancer cells, overexpression of CEACAM6 is associated with anoikis resistance, metastasis, and gemcitabine resistance [11,21,23,24]. Furthermore, overexpression of the protein is correlated with reduced survival and the development of metastasis in colorectal cancer patients [9,14,25], and is a significant predictor of recurrence in breast cancer [26].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, miR-29a has a tumor suppressive role in restricting the activity of DNA damage responsive kinases such as Cdc7 in lung cancer cells [37]. Recently, Chen et al reported that CEACAM6 directly impacts the epithelial-mesenchymal transition, migration, invasion, and metastasis of pancreatic cancer cells, and showed that miR-29a/b/c can regulate CEACAM6 at the post-transcriptional level in pancreatic cancer [24]. Therefore, miR-29a may act as a tumor suppressor in lung adenocarcinoma and pancreatic cancer by inhibiting the expression of CEACAM6.…”
Section: Discussionmentioning
confidence: 99%